GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly emerging as a major focus in medical investigation, largely due to its notable impact on treating conditions such as second type diabetes and weight gain. Ongoing research have demonstrated that beyond glucose regulation, GLP-1 drugs offer promise for heart function and possibly